Showing results (21-30 of 366) with videos related to
Sort By:
Pageof 37
Nuclear Medicine and Biology|December 21, 2004
Synthesis of [18F]Xeloda as a novel potential PET radiotracer for imaging enzymes in cancersXiangshu Fei, Ji-Quan Wang, Kathy D Miller, et al.Steroids|June 30, 2009
Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancerMin Wang, Jarrett Mickens, Mingzhang Gao, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 6, 2008
Synthesis of new carbon-11 labeled naphthalene-sulfonamides for PET imaging of human CCR8Min Wang, Benjamin Cooley, Mingzhang Gao, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 18, 2010
Synthesis of carbon-11-labeled tricyclic necroptosis inhibitors as new potential PET agents for imaging of tumor necrosis factor alpha (TNF-alpha)Mingzhang Gao, Christian M Lola, Min Wang, et al.Bioorganic & Medicinal Chemistry|September 12, 2006
Synthesis of carbon-11 labeled fluorinated 2-arylbenzothiazoles as novel potential PET cancer imaging agentsMin Wang, Mingzhang Gao, Bruce H Mock, et al.Investigational New Drugs|September 14, 2006
Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancerJehana James, Daryl J Murry, Anthony M Treston, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|December 25, 2007
Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptorsMingzhang Gao, Min Wang, Bruce H Mock, et al.Oncology (Williston Park, N.Y.)|June 20, 2008
The new millennium for adjuvant therapy in breast cancerGeorge W SledgeBreast (Edinburgh, Scotland)|August 21, 2007
The evolution of targeted biologic therapiesGeorge W SledgePageof 37